By activating the (protein kinase B) AKT/mTOR (mammalian target of rapamycin) pathway and promoting epithelial–mesenchymal transition (EMT), fibrinogen may simultaneously encourage hepatoma cell motility and invasion. Here, AKT1 is linked to hepatocellular carcinoma.